In most situations, the main reasons for poor results are low bioavailability and poor ocular penetration of the currently available antifungal drugs to the intended site of action [44]
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
It could possibly help in the repair of the brain and nerves in neurological disease
Use within 30 days of opening
[6:08 PM]source: BPC-157 Oral vs Injection: Benefits, Risks, and Efficacy When comparing the two routes, consider onset of action, safety, convenience, and cost
These scenarios benefit from higher systemic peptide levels and potentially from injection near the injury site